Sonoma Pharmaceuticals (SNOA) Invested Capital: 2011-2012
Historic Invested Capital for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $547,000.
- Sonoma Pharmaceuticals' Invested Capital rose 456.37% to $6.2 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.2 million, marking a year-over-year increase of 456.37%. This contributed to the annual value of $547,000 for FY2012, which is 79.03% down from last year.
- Sonoma Pharmaceuticals' Invested Capital amounted to $547,000 in FY2012, which was down 79.03% from $2.6 million recorded in FY2011.
- In the past 5 years, Sonoma Pharmaceuticals' Invested Capital ranged from a high of $2.6 million in FY2011 and a low of $547,000 during FY2012.
- Over the past 2 years, Sonoma Pharmaceuticals' median Invested Capital value was $1.6 million (recorded in 2011), while the average stood at $1.6 million.
- Data for Sonoma Pharmaceuticals' Invested Capital shows a maximum YoY tumbled of 79.03% (in 2012) over the last 5 years.
- Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Invested Capital stood at $2.6 million in 2011, then slumped by 79.03% to $547,000 in 2012.